Merck KGaA (OTCMKTS:MKGAF – Get Free Report) is anticipated to post its results before the market opens on Thursday, August 6th. Analysts expect Merck KGaA to post earnings of $2.31 per share and revenue of $6.0418 billion for the quarter.
Merck KGaA Price Performance
Shares of OTCMKTS:MKGAF opened at $165.00 on Tuesday. The firm has a 50 day simple moving average of $160.37 and a 200 day simple moving average of $147.26. The company has a market cap of $21.32 billion, a price-to-earnings ratio of 25.19 and a beta of 0.96. The company has a debt-to-equity ratio of 0.27, a current ratio of 1.31 and a quick ratio of 0.84. Merck KGaA has a one year low of $116.68 and a one year high of $175.56.
Merck KGaA Company Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Read More
- Five stocks we like better than Merck KGaA
- Tether Strikes Gold: Crypto’s Physical Pivot
- Jersey Mike’s Serves Fresh Gains After IPO Stumble
- 3 Drone Stocks That Should Soar After the Summer Slump
- Tyson Foods Offers a Meaty Opportunity for Income Investors
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
